By 2050, the number of people living with diabetes is projected to rise to 853 million. In the past 5 years, ICON has conducted 187 metabolic studies involving 41,000+ patients and healthy volunteers at 6,600+ sites, inc...
- Home
- Sectors
Sectors
ICON provides its full range of clinical, consulting and commercial services across several sectors.
-
Biotech
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
-
Government and Public Health Solutions
ICON provides federal and NGO clients with development and staffing services across areas such as vaccines, biothreats response and working in Africa.
-
Medical Device
ICON understands the unique requirements of medical devices, diagnostics, and combination drug/device and biologic/device products.
-
Pharmaceuticals
ICON has worked with many of the world’s pharmaceutical firms, developing strategic partnerships with some of the world’s largest.